Immunome Inc
NASDAQ:IMNM 3:59:51 PM EDT
Earnings Announcements
Immunome Reports First Quarter 2022 Financial Results
Published: 05/12/2022 12:34 GMT
Immunome Inc (IMNM) - Immunome Reports First Quarter 2022 Financial Results.
Qtrly Loss per Share $0.96.
As of March 31, 2022, Cash and Cash Equivalents Totaled $42.9 Million.
Qtrly Loss per Share $0.96.
As of March 31, 2022, Cash and Cash Equivalents Totaled $42.9 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.82
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.75
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.82
More details on our Analysts Page.